3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Follicular
4
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Lymphoma, B-Cell
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, T-Cell
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Urinary Bladder Neoplasms
1
Tertiary Lymphoid Structures
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Rituximab
28
acalabrutinib
14
ibrutinib
13
Cyclophosphamide
13
CT-P10
12
Lenalidomide
11
zanubrutinib
9
Magnetic Resonance Spectroscopy
9
venetoclax
8
Specimen Handling
8
obinutuzumab
7
Cytarabine
7
Biopsy
7
pirtobrutinib
6
glofitamab
6
fludarabine
6
Bendamustine Hydrochloride
6
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Whole-Body Irradiation
4
Vincristine
4
Mycophenolic Acid
4
Etoposide
4
Doxorubicin
4
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
tazemetostat
×
90 days
×
Clear all
No trials found.